Latest Advisory

  • PUBLIC SERVICE ANNOUNCEMENT PO MULA SA FOOD AND DRUG ADMINISTRATION

    PUBLIC SERVICE ANNOUNCEMENT PO MULA SA FOOD AND DRUG ADMINISTRATION

    Read more

  • MARCHING ORDERS

    MARCHING ORDERS

    Read more

  • FDA Advisory No. 2017-251 || Voluntary Recall of QIAamp DSP Virus Kit  CE

    FDA Advisory No. 2017-251 || Voluntary Recall of QIAamp DSP Virus Kit CE

    Read more

  • FDA Advisory No. 2017-244 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements and Food Products:

    FDA Advisory No. 2017-244 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements and Food Products:

    Read more

  • FDA Advisory No. 2017-243-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Pekeng Bersyon ng Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    FDA Advisory No. 2017-243-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng Pekeng Bersyon ng Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    Read more

  • FDA Advisory No. 2017-243 || Public Health Warning Against the Purchase and Use of the Counterfeit Version of Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    FDA Advisory No. 2017-243 || Public Health Warning Against the Purchase and Use of the Counterfeit Version of Dydrogesterone (Duphaston) 10 mg Film-coated Tablet

    Read more

  • FDA Advisory No. 2017-242-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot na:

    FDA Advisory No. 2017-242-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Hindi Rehistradong Gamot na:

    Read more

  • FDA Advisory No. 2017-242 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

    FDA Advisory No. 2017-242 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:

    Read more

  • FDA sets first regulatory fair on Aug. 17-18 at PICC

    FDA sets first regulatory fair on Aug. 17-18 at PICC

    Read more

  • FDA holds first regulatory exhibit

    FDA holds first regulatory exhibit

    Read more

  • A ‘new’ FDA

    A ‘new’ FDA

    Read more

  • FDA Advisory No. 2017-250 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplement:

    FDA Advisory No. 2017-250 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplement:

    Read more

  • FDA Advisory No. 2017-249 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-249 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2017-247 || Public Health Warning Against Unapproved  Advertisement and Promotion of Unregistered V-MORINGA Capsule  with Therapeutic Claims

    FDA Advisory No. 2017-247 || Public Health Warning Against Unapproved Advertisement and Promotion of Unregistered V-MORINGA Capsule with Therapeutic Claims

    Read more

  • FDA Advisory No. 2017-246 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    FDA Advisory No. 2017-246 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Supplements:

    Read more

  • FDA Advisory No. 2017-245 || Public Health Warning Against the following Unregistered Food Supplements with their Corresponding Unapproved and Misleading Advertisements and Promotion:

    FDA Advisory No. 2017-245 || Public Health Warning Against the following Unregistered Food Supplements with their Corresponding Unapproved and Misleading Advertisements and Promotion:

    Read more

  • FDA Advisory No. 2017-241 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-241 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2017-240 || Public Health Warning Against the following Unregistered Food Supplements with Misleading Claims Being Sold Online:

    FDA Advisory No. 2017-240 || Public Health Warning Against the following Unregistered Food Supplements with Misleading Claims Being Sold Online:

    Read more

  • FDA Advisory No. 2017-239 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    FDA Advisory No. 2017-239 || Public Health Warning Against the Purchase and Consumption of the following Unregistered Food Products and Food Supplements:

    Read more

  • FDA Advisory No. 2017-237 || VOLUNTARY PRODCUCT RECALL OF PHYSIOMESH COMPOSITE MESH (MDR-00270)

    FDA Advisory No. 2017-237 || VOLUNTARY PRODCUCT RECALL OF PHYSIOMESH COMPOSITE MESH (MDR-00270)

    Read more

RELOCATION AND OPERATION OF FDAC AT THE 4TH FLOOR, CIVIC PRIME BUILDING, CIVIC DRIVE, FILINVEST CORPORATE CITY, ALABANG,  MUNTINLUPA CITY STARTING 24 JULY 2017 (MONDAY)

In connection to the FDA Advisory No. 2017-204 titled “Relocation of the Food and Drug Action Center (FDAC)”, all transactions in the FDA PAIR Unit at Room 106 will be entertained at new FDAC Office located at Civic Prime Bldg., Civic Drive, Alabang Muntinlupa City, starting on Monday, July 24, 2017.

For your information, guidance and compliance.

Attachments:
Download this file (FDAC- Announcement.pdf)FDAC- Announcement.pdf

FDA Memorandum Circular No. 2017-002

1st Food and Drug Administration (FDA) Regulatory Advocacy Fair and Back-to-back Qualified Person in the Industry Regulatory Affairs (QPIRA) Trainings

I. BACKGROUND

The Food and Drug Administration will hold the 1st FDA Regulatory Advocacy Fair coinciding its 54 years as health product regulator. Timely with the celebration, FDA will be holding activities which not only showcase the Agency’s milestones but extend its services to valued stakeholders. One of the main activities is the Qualified Person in the Industry Regulatory Affairs (QPIRA) training. In this event, subject to rules and guidelines that will be strictly implemented, FDA will have an avenue to promote awareness and learning for its stakeholders, to showcase industry best practices, professional organization membership, regulatory affairs success stories; quality management programs, good manufacturing practices, product safety projects, and anti-counterfeit programs, and the like. With corresponding fees and charges, booths will be opened for Stakeholder Organizations strongly promoting the Agency’s advocacies as mentioned as a way to enhance stakeholder engagement and learning.

Attachments:
Download this file (FMC2017-002.pdf)FMC2017-002.pdf

Submission of Comments on Draft Policies by the Center for Food Regulation and Research Extended

Please be informed that the Center for Food Regulation and Research (CFRR) has extended the period for submission of comments on the updated draft regulatory policies:

Title:

Recipient’s email address:

Due date:

A.    Draft Administrative Order - Revised Regulatory Guidelines Concerning Food Additives and Processing Aids

This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it.

Cc:  This email address is being protected from spambots. You need JavaScript enabled to view it.

July 31, 2017

 

B.     Draft Administrative - Order Adoption of all Philippine National Standards (PNS) Approved and Issued by the FDA and Other Standards as Technical Regulation

This email address is being protected from spambots. You need JavaScript enabled to view it.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Cc:  This email address is being protected from spambots. You need JavaScript enabled to view it.

August 13, 2017

C.     Draft FDA Circular - Rules and Guidelines on the Rules and Guidelines on the Issuance of Import Permit as “Samples Only” for FDA Regulated Products Intended for Research and Development Purposes

This email address is being protected from spambots. You need JavaScript enabled to view it.

Cc:  This email address is being protected from spambots. You need JavaScript enabled to view it.

 

August 13, 2017

For your information and guidance.

 

Thank you.

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter